Platinum compounds: a new class of potent antitumour agents.
about
The therapeutic potential of metal-based antimalarial agents: implications for the mechanism of actionFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityCancer chemotherapy: past, present, and future--Part IElectrolytic ablation of the rat pancreas: a feasibility trialGenotoxic anti-cancer agents and their relationship to DNA damage, mitosis, and checkpoint adaptation in proliferating cancer cellsSystems biology of cisplatin resistance: past, present and futureMechanisms of Cisplatin nephrotoxicityStructure of duplex DNA containing the cisplatin 1,2-{Pt(NH3)2}2+-d(GpG) cross-link at 1.77Å resolutionConsequences of Cisplatin Binding on Nucleosome Structure and DynamicsStructural basis of human DNA polymerase η-mediated chemoresistance to cisplatin.Interactions of gold-based drugs with proteins: crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold(III) compoundThe primary mode of binding of cisplatin to a B-DNA dodecamer: C-G-C-G-A-A-T-T-C-G-C-GThe Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) ProdrugsAdvances and Challenges in Viability Detection of Foodborne PathogensAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityAnti-Candida activity of a new platinum derivativeDetoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatinHistological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]ClA novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathyChemopreventive evaluation of a Schiff base derived copper (II) complex against azoxymethane-induced colorectal cancer in ratsA better experimental method to detect the sensitivity of cancer cells to anticancer drugs after adenovirus-mediated introduction of two kinds of p53 in vivoAnti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine AgentOne-dimensional Magnus-type platinum double saltsSynthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexesSpectroscopic investigation of Bovine Liver Catalase interactions with a novel phen-imidazole derivative of platinum.Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.Anticancer activity of methyl-substituted oxaliplatin analogs.Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands.Photoinduced intercalation and coordination of a dirhodium complex to DNA: dual DNA binding.An unusual ligand coordination gives rise to a new family of rhodium metalloinsertors with improved selectivity and potency.Effect of Different Z-Inducers on the Stabilization of Z Portion in BZ-DNA Sequence: Correlation Between Experimental and Simulation Data.Synthesis, characterization and biological activity of trans-platinum(II) and trans-platinum(IV) complexes with 4-hydroxymethylpyridine.Synthesis, characterization, DNA binding, cleavage activity, cytotoxicity and molecular docking of new nano water-soluble [M(5-CH₂PPh₃-3,4-salpyr)](ClO₄)₂ (M = Ni, Zn) complexes.Molecular structure and cytotoxicity of 3D-transition metal complexes capable to form a stable metal-nitrogen bond.Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy.Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate.
P2860
Q20906133-783C8B16-37FA-4D93-A035-9128A7543C06Q24236119-01A4746E-B78E-4EA0-9D4A-A678A5081676Q24242032-345C5978-F359-4398-A8B0-6636DAF57A81Q24657512-6D1ADA29-8702-4655-9C9A-5E22EF128624Q24804655-3B2A6C58-BA72-40FA-8436-A616A487A747Q26851196-5473B855-361E-4708-972C-844BC0F47E55Q26863585-66B4E802-148D-48CA-9B0D-3ADB180F04B4Q26996320-3A5D5664-2B3C-44DA-A8E0-12C7108563ABQ27662176-F926B0DA-3977-43F7-B18F-EB1645CC2B40Q27666340-B470000F-4131-416A-9343-5A437590942CQ27678705-248A1321-C6DC-4EA9-86AF-570D3F318062Q27687736-CAECAEE4-5A1F-4085-A34F-68BA234AB6F2Q27729148-AEB48F3F-18CF-4592-8CF7-CF19F0053454Q28066801-C9C08E99-E54F-4092-A9F4-48CECE17DBF9Q28072577-846E2ED6-9480-4AE7-ABEF-899094F70375Q28080615-C1985131-3141-4717-BFF5-506EDF2C225DQ28344764-351F99F2-FE7D-4A1D-82FD-C574C5D8A27DQ28484446-0FE8607F-EDC2-4843-AAEE-95E47079A871Q28484603-281A9DCA-D317-474D-8038-A33BC98FEDE5Q28484947-9ACAB11E-4046-4E76-99A9-0C81CF91154EQ28540744-CB7CDEBF-6FBD-4A26-B5B6-874852AD4784Q28546961-B3F0FF8C-EF33-41E0-90F5-ECC620099633Q28553698-D390D099-08E7-47ED-89E3-58A90989D269Q28829576-49C902DB-4852-48D7-9A30-9FCFB81765C7Q30358389-6DE96DA7-047A-4C88-8448-B3DF09356270Q30398128-D496C102-2BEF-40A4-8705-660208CFDF71Q30447637-050F4846-1D87-40AD-81AF-2B7734C371A2Q30515979-578B7BE4-E52A-4D74-A583-A644B87860B5Q30607784-39A36AB2-9F03-4C10-AE24-D09D329F1A22Q30806098-35182B14-8E0A-4CC9-B8C6-7AE27CC90E43Q30855124-59605501-5E2C-42AB-BFA2-7D618CD6284AQ30993331-440A66F7-DD64-489F-A6DD-5F0C33F59F99Q31011200-66EF4FFC-5CA9-4A23-A897-FA3568989C32Q31056225-F692BFD7-1BA9-4896-B2D1-A2FF20D902EDQ31630775-A25742E2-44F0-4781-A5FC-E60D7547AAC2Q32103947-236EA691-FB39-47C0-A095-1A3749062C8BQ33385228-11489FCE-39FB-4941-B0D4-CB3E70C86FB8Q33494306-9DA59DAF-BC7E-4C1F-9CD7-00970CA1F6B2Q33506479-8CE821A0-7F62-4B02-BAAB-CC9D5947A143Q33564338-3C7775BB-9E55-4E56-997E-3F3AF03B66B7
P2860
Platinum compounds: a new class of potent antitumour agents.
description
1969 nî lūn-bûn
@nan
1969 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1969 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1969年の論文
@ja
1969年論文
@yue
1969年論文
@zh-hant
1969年論文
@zh-hk
1969年論文
@zh-mo
1969年論文
@zh-tw
1969年论文
@wuu
name
Platinum compounds: a new class of potent antitumour agents.
@ast
Platinum compounds: a new class of potent antitumour agents.
@en
Platinum compounds: a new class of potent antitumour agents.
@nl
type
label
Platinum compounds: a new class of potent antitumour agents.
@ast
Platinum compounds: a new class of potent antitumour agents.
@en
Platinum compounds: a new class of potent antitumour agents.
@nl
prefLabel
Platinum compounds: a new class of potent antitumour agents.
@ast
Platinum compounds: a new class of potent antitumour agents.
@en
Platinum compounds: a new class of potent antitumour agents.
@nl
P2093
P356
P1433
P1476
Platinum compounds: a new class of potent antitumour agents.
@en
P2093
Mansour VH
Rosenberg B
P2888
P304
P356
10.1038/222385A0
P407
P577
1969-04-01T00:00:00Z
P5875
P6179
1001455608